CLASS II Drug recall · Reported 18 Jul 2018 · FDA Enforcement Report

Fluocinolone Acetonide Topical Solution recalled

Teva Pharmaceuticals USA is recalling Fluocinolone Acetonide Topical Solution, USP, 0.01%, distributed nationwide in the US. The recall was initiated on 5 Jul 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: 1164898, EXP 10/18; 1164904, 1164909, EXP 11/18; 1211396, EXP 07/19; 1230808, 1231127, EXP 01/20
NDC0591-2990
Quantity recalled27,803 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0909-2018
FDA event ID
80437
Recalling firm
Teva Pharmaceuticals USA, North Wales, PA
Manufacturer
Actavis Pharma, Inc.
Classification
Class II
Status
Terminated
Recall initiated
5 Jul 2018
FDA classified
6 Jul 2018
Reported
18 Jul 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

5 Jul 2018Recall initiated by company
6 Jul 2018Classified by FDA+1 day
18 Jul 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Fluocinolone Acetonide Topical Solution, USP, 0.01%, 60 mL bottle, Rx Only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108 USA; Distributed by: Actavis Pharmac, Inc., Parsippany, NJ 07054 USA, NDC 0591-2990-60.

Where it was distributed

Nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.

Which lots are affected?

Lot #s: 1164898, EXP 10/18; 1164904, 1164909, EXP 11/18; 1211396, EXP 07/19; 1230808, 1231127, EXP 01/20

Where was it sold?

Nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 280

Other Fluocinolone Acetonide recalls

All 14